Oncotarget · 2016 · 25 citations · 33 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular OncologySignal TransductionApoptosis In CancerApoptosis RegulationCancer Cell SignalingNuclear ReceptorsSignal Transduction In CancerTumor Suppressor GenesAmp-activated Protein Kinase InteractionCancer Cell Survival SignalingNuclear Hormone Receptor SignalingNuclear Receptor Signaling PathwaysRetinoid ReceptorsRor Nuclear ReceptorsTnm Staging SystemTumor Suppressor Loss
// Zhengguang Wang 1 , Fangyuan Xiong 2 , Xiaoshan Wang 1 , Yijun Qi 1 , Haoyuan Yu 1 , Yong Zhu 1 , Huaqing Zhu 2 1 Department of Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China 2 Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei, Anhui, P.R. China Correspondence to: Zhengguang Wang, email: wangzhengguang@ahmu.edu.cn Keywords: gastric carcinoma, RORα, AMPK, apoptosis, chemotherapy resistance Received: November 02, 2016 Accepted: December 23, 2016 Published: December 29, 2016 ABSTRACT Retinoid-related orphan receptor α (RORα) is a nuclear receptor, which regulates inflammation and immune responses, lipid metabolism and circadian rhythm. Although RORα suppresses breast tumor invasion, it is unknown whether RORα is dysregulated in gastric cancer leading to cellular survival. Therefore, we hypothesize that RORα is dysfunctional in gastric carcinoma and this causes decreased apoptosis in gastric cancer cells. To test this hypothesis, we employed human gastric cancer tissues with different stages to determine RORα expression, as well as in vitro human gastric cancer cells to determine how RORα is reduced during apoptosis. We found that the expression of RORα was reduced in gastric tissues with cancer, and this correlated with increased TNM stages. The mechanisms underlying RORα reduction is due to the reduced activation of AMP-activated protein kinase (AMPK), as a selective AMPK activator AICAR increased RORα activation and level in human gastric cancer cells. Furthermore, AICAR treatment increased RORα recruitment on the promoters of tumor suppressor genes (i.e., FBXM7, SEMA3F and p21) leading to apoptosis in human gastric cancer cells. Taken together, RORα reduction occurs in gastric cancer leading to the survival of tumor cells, which is attenuated by AMPK. Therefore, both RORα and AMPK are potential targets for the intervention and therapy in gastric carcinoma.
33
Recent patterns in gastric cancer: A global overview
Paola Bertuccio, Liliane Chatenoud, Fabio Levi et al. · International Journal of Cancer · 2009 · 638 citations · Full text
Transcription factor RORα is critical for nuocyte development
See Heng Wong, Jennifer A. Walker, Helen E. Jolin et al. · Nature Immunology · 2012 · 567 citations · Full text
Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980
Cristina Bosetti, Paola Bertuccio, Matteo Malvezzi et al. · Annals of Oncology · 2013 · 465 citations · Full text
Satoshi Yamashita, Yoshimi Tsujino, Kazuki Moriguchi et al. · Cancer Science · 2005 · 256 citations · Full text
Life Sciences, Genetics, Oncology +17